Phase II Data Support Potential for Novel

Phase II Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People With Diabetic Macular Edema RG7716 is the first bispecific antibody designed specifically for the treatment of retinal eye diseases RG7716 demonstrated...

MyEye 2.0 shown in UK

MyEye 2.0 shown in UK after winning plaudits at CES By Guy Campos The award-winning artificial vision aid, from OrCam, won the Last Gadget Standing award, as well as being an Innovation Awards honouree in the accessible tech category at CES 2018. OrCam Technologies,...
On